Three Years of Lebrikizumab Kept Atopic Dermatitis Controlled in Long-Term Extension Analysis
A post hoc analysis of week 16 responders from the ADvocate trials found that most maintained deep skin and itch ...
A post hoc analysis of week 16 responders from the ADvocate trials found that most maintained deep skin and itch ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine